PACT Pharma
PACT Pharma is synthesizing neo-epitope targeted T cells and producing a personalized adoptive cell therapy designed to benefit each cancer patient.
3
Funding Rounds
$200.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Da*** Ba******* | - | - | - |
| An**** Ri*** | - | - | |
| Ji* He*** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company PACT Pharma has raised a total of $200m in funding over 3 rounds.
Key Insights:
- PACT Pharma Series C round, January 11, 2020: $75m
- PACT Pharma Series B round, May 25, 2018: $95m
- PACT Pharma Series A round, December 20, 2016: $30m
PACT Pharma Series C round, January 11, 2020
$75m
PACT Pharma Series B round, May 25, 2018
$95m
PACT Pharma Series A round, December 20, 2016
$30m
Industries
PACT Pharma is active in the following industries: